Skip to main content
Market intelligence
RYTMHealthcare

Rhythm Pharmaceuticals Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 13, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 13, 2026Joseph ShulmanChief Technical OfficerSale5,079$119.75$608,210
Aug 13, 2026Alastair GarfieldChief Scientific OfficerSale7,763$117.57$912,703
Aug 13, 2026Jennifer Kayden LeeEVP, Head of North AmericaSale75,834$117.38$8,901,531